EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Significance of Apoptosis Marker Caspase-3, Tumor Marker CEA, and Electrolyte Imbalance in Breast Cancer Patients

Ahmed A. Al Shammari, Wasan Nazhan Hussein

Archives of Breast Cancer · 25.07.2026 · 13 (3) · 342-347

DOI: 10.32768/abc.9862741053-812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Breast Cancer, online erschienen am 25.07.2026. Verfasst von Ahmed A. Al Shammari und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reliable circulating biomarkers remain clinically important in the evaluation of breast cancer. This cross-sectional study assessed serum caspase-3, carcinoembryonic antigen (CEA), and certain electrolyte parameters in a control group of healthy individuals and breast cancer patients at different clinical stages.

Methods

Ninety female participants were divided into Control (n=30), Newly Diagnosed (G1, n=20), and Treated (G2, n=40) groups. Serum Caspase-3, CEA, and electrolytes (Zn2+, Ca2+, Na+, K+) were measured. Blood samples in the treated group were collected after completion of the fourth chemotherapy cycle during routine follow-up visits. No participants were excluded after laboratory analysis due to missing biomarker data. Data were analyzed using ANOVA and ROC curves. A p-value < 0.05 was considered statistically significant.

Results

Caspase-3 levels were lowest in the newly diagnosed group (G1), whereas treated patients (G2) showed higher values than G1. One-way ANOVA demonstrated a statistically significant difference among the study groups for Caspase-3 (p = 0.004). CEA concentrations also differed significantly between groups (p = 0.002). Significant differences were observed for Zn²⁺ (p < 0.001), Ca²⁺ (p < 0.0001), Na⁺ (p < 0.001), and K⁺ (p < 0.0001). ROC analysis indicated moderate diagnostic performance for CEA (AUC = 0.7537).

Conclusion

Between-group differences were observed in serum Caspase-3, CEA, and selected electrolyte levels.

Zitieren

APA

Shammari, A. A. A., & Hussein, W. N. (2026). Clinical Significance of Apoptosis Marker Caspase-3, Tumor Marker CEA, and Electrolyte Imbalance in Breast Cancer Patients. Archives of Breast Cancer, 13(3), 342-347. https://doi.org/10.32768/abc.9862741053-812

Vancouver

Shammari AAA, Hussein WN. Clinical Significance of Apoptosis Marker Caspase-3, Tumor Marker CEA, and Electrolyte Imbalance in Breast Cancer Patients. Archives of Breast Cancer. 2026;13(3):342-347. doi:10.32768/abc.9862741053-812

BibTeX
@article{Shammari2026,
  author = {Shammari, Ahmed A. Al and Hussein, Wasan Nazhan},
  title = {Clinical Significance of Apoptosis Marker Caspase-3, Tumor Marker CEA, and Electrolyte Imbalance in Breast Cancer Patients},
  journal = {Archives of Breast Cancer},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {342--347},
  doi = {10.32768/abc.9862741053-812}
}
Kostenlos starten →